[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621349":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":11,"centralContacts":16,"locations":10,"responsibleParty":25,"collaborators":10,"id":29,"slug":30,"hasResults":31,"nctId":32,"briefTitle":33,"officialTitle":34,"acronym":10,"eligibilityCriteria":35,"healthyVolunteers":31,"sex":36,"minAge":37,"maxAge":10,"enrollmentInfo":38,"targetDuration":10,"studyType":41,"phases":10,"briefSummary":42,"conditions":43,"keywords":46,"overallStatus":52,"whyStopped":10,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":10},{"fullName":5,"class":6},"Chinese PLA General Hospital","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"Older T2DM Hepatectomy Cohort",null,[12],{"name":13,"affiliation":14,"role":15},"Weidong Mi, Professor","The First Medical Center of Chinese PLA General Hospital","STUDY_CHAIR",[17,21],{"name":13,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","86+13381082966","wwdd1962@163.com",{"name":22,"role":18,"phone":23,"phoneExt":10,"email":24},"Danyang Geng, Master","86+17367522284","sphm123@126.com",{"type":26,"investigatorFullName":27,"investigatorTitle":28,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Weidong Mi","Chief Physician","100621349","association-of-preoperative-hippocampal-glucose-metabolism-with-postoperative-delirium-in-older-diabetic-patients-100621349",false,"NCT07369466","Association of Preoperative Hippocampal Glucose Metabolism With Postoperative Delirium in Older Diabetic Patients","Preoperative Hippocampal Glucose Metabolism Levels and the Risk of Postoperative Delirium in Older Patients With Type 2 Diabetes: A Prospective Cohort Study","Inclusion Criteria:\n\n1. Diagnosed with type 2 diabetes mellitus (T2DM).\n2. Age ≥ 65 years.\n3. Scheduled for elective liver tumor resection surgery with an expected operative duration \\> 2 hours.\n4. Underwent whole-body ¹⁸F-FDG PET\u002FCT scan within 1 month prior to surgery.\n\nExclusion Criteria:\n\n1. Patient declines to participate.\n2. Inability to cooperate with cognitive assessments or a preoperative Mini-Mental State Examination (MMSE) score \\\u003C 23.\n3. American Society of Anesthesiologists (ASA) physical status classification ≥ IV.\n4. History of organic brain disorders, including stroke, traumatic brain injury, or intracranial tumors.\n5. History of psychiatric disorders or current use of antipsychotic medications.","ALL","65 Years",{"count":39,"type":40},154,"ESTIMATED","OBSERVATIONAL","Objective: To investigate the association between preoperative hippocampal glucose metabolism levels and the risk of postoperative delirium (POD) in elderly patients with type 2 diabetes (T2DM), and to provide a prospective neuroimaging biomarker for identifying high-risk populations.\n\nMethods: This prospective cohort study plans to enroll 154 elderly T2DM patients scheduled for liver tumor resection at the First Medical Center of Chinese PLA General Hospital. Baseline cognitive function will be assessed using the Mini-Mental State Examination (MMSE) one day before surgery. Hippocampal glucose metabolism will be quantitatively evaluated by measuring the mean standardized uptake value (SUVmean) of bilateral hippocampi using ¹⁸F-FDG PET\u002FCT. POD will be assessed twice daily from postoperative days 1 to 7 using the 3-Minute Diagnostic Interview for CAM (3D-CAM). The correlation between preoperative hippocampal SUVmean and POD incidence will be analyzed using univariate and multivariate logistic regression models. The predictive performance will be evaluated by constructing receiver operating characteristic (ROC) curves. Furthermore, the relationship between a peripheral insulin resistance marker (the triglyceride-glucose index, TyG index) and hippocampal metabolism levels will be analyzed.\n\nSignificance: This study aims to determine whether impaired preoperative hippocampal metabolism serves as an independent risk factor for POD. The findings are expected to provide a prospective functional neuroimaging biomarker for the early warning of POD and offer a theoretical basis for developing precise prevention strategies targeting cerebral metabolic abnormalities. This will facilitate the application of neuroimaging techniques in the field of perioperative brain dysfunction monitoring.",[44,45],"Postoperative Delirium","Type 2 Diabetes",[47,48,49,50,51],"Postoperative delirium","Type 2 Diabetes Mellitus","Positron-Emission Tomography","Hippocampus","Glucose metabolism","NOT_YET_RECRUITING","2026-01-18",{"date":55,"type":56},"2026-01-27","ACTUAL",{"date":58,"type":40},"2026-02-01",{"date":60,"type":40},"2028-06-01",{"name":5,"class":6}]